181 related articles for article (PubMed ID: 23668885)
1. Nanoscale obstacle arrays frustrate transport of EphA2-Ephrin-A1 clusters in cancer cell lines.
Lohmüller T; Xu Q; Groves JT
Nano Lett; 2013 Jul; 13(7):3059-64. PubMed ID: 23668885
[TBL] [Abstract][Full Text] [Related]
2. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.
Himanen JP; Goldgur Y; Miao H; Myshkin E; Guo H; Buck M; Nguyen M; Rajashankar KR; Wang B; Nikolov DB
EMBO Rep; 2009 Jul; 10(7):722-8. PubMed ID: 19525919
[TBL] [Abstract][Full Text] [Related]
3. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
Xu Q; Lin WC; Petit RS; Groves JT
Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
[TBL] [Abstract][Full Text] [Related]
4. Restriction of receptor movement alters cellular response: physical force sensing by EphA2.
Salaita K; Nair PM; Petit RS; Neve RM; Das D; Gray JW; Groves JT
Science; 2010 Mar; 327(5971):1380-5. PubMed ID: 20223987
[TBL] [Abstract][Full Text] [Related]
5. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
6. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
7. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
8. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
[TBL] [Abstract][Full Text] [Related]
9. Localized Intercellular Transfer of Ephrin-As by Trans-endocytosis Enables Long-Term Signaling.
Valenzuela JI; Perez F
Dev Cell; 2020 Jan; 52(1):104-117.e5. PubMed ID: 31866204
[TBL] [Abstract][Full Text] [Related]
10. EphA2/Ephrin-A1 Mediate Corneal Epithelial Cell Compartmentalization via ADAM10 Regulation of EGFR Signaling.
Kaplan N; Ventrella R; Peng H; Pal-Ghosh S; Arvanitis C; Rappoport JZ; Mitchell BJ; Stepp MA; Lavker RM; Getsios S
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):393-406. PubMed ID: 29351356
[TBL] [Abstract][Full Text] [Related]
11. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.
Youngblood VM; Kim LC; Edwards DN; Hwang Y; Santapuram PR; Stirdivant SM; Lu P; Ye F; Brantley-Sieders DM; Chen J
Cancer Res; 2016 Apr; 76(7):1825-36. PubMed ID: 26833123
[TBL] [Abstract][Full Text] [Related]
12. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction.
Goichberg P; Bai Y; D'Amario D; Ferreira-Martins J; Fiorini C; Zheng H; Signore S; del Monte F; Ottolenghi S; D'Alessandro DA; Michler RE; Hosoda T; Anversa P; Kajstura J; Rota M; Leri A
Circ Res; 2011 Apr; 108(9):1071-83. PubMed ID: 21415392
[TBL] [Abstract][Full Text] [Related]
13. EphA2 Transmembrane Domain Is Uniquely Required for Keratinocyte Migration by Regulating Ephrin-A1 Levels.
Ventrella R; Kaplan N; Hoover P; Perez White BE; Lavker RM; Getsios S
J Invest Dermatol; 2018 Oct; 138(10):2133-2143. PubMed ID: 29705292
[TBL] [Abstract][Full Text] [Related]
14. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
15. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
16. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
17. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
[TBL] [Abstract][Full Text] [Related]
18. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
[TBL] [Abstract][Full Text] [Related]
19. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
20. Receptor-binding domain of ephrin-A1: production in bacterial expression system and activity.
Nekrasova OV; Sharonov GV; Tikhonov RV; Kolosov PM; Astapova MV; Yakimov SA; Tagvey AI; Korchagina AA; Bocharova OV; Wulfson AN; Feofanov AV; Kirpichnikov MP
Biochemistry (Mosc); 2012 Dec; 77(12):1387-94. PubMed ID: 23244735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
